Selected research
Industry Research
Metformin HCl API Industry Research Report 2026
Market perspective
The global Metformin HCl API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metformin HCl API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metformin HCl API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metformin HCl API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metformin HCl API include Shijiazhuang Polee Pharmaceutical, Shouguang Fukang Pharmaceutical, CR Double-Crane, Vistin Pharma, IOLCP, Harman Finochem, Farmhispania, Exemed Pharmaceuticals and Bhupinder Singh Manhas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metformin HCl API market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metformin HCl API Market by Company
Shijiazhuang Polee Pharmaceutical
Shouguang Fukang Pharmaceutical
CR Double-Crane
Vistin Pharma
IOLCP
Harman Finochem
Farmhispania
Exemed Pharmaceuticals
Bhupinder Singh Manhas
Auro Laboratories Limited
Atom Pharma
Anant Pharmaceuticals Pvt. Ltd.
Abhilasha Pharma Pvt. Ltd.
Aarti Drugs
Metformin HCl API Segment by Type
0.995
0.99
0.97
Others
Metformin HCl API Segment by Application
Pharmaceutical Companies
Contract Research Organizations
Others
Metformin HCl API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin HCl API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin HCl API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin HCl API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metformin HCl API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metformin HCl API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metformin HCl API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 0.995
- 0.99
- 0.97
- Others
Applications
- Pharmaceutical Companies
- Contract Research Organizations
- Others
Companies covered
- Shijiazhuang Polee Pharmaceutical
- Shouguang Fukang Pharmaceutical
- CR Double-Crane
- Vistin Pharma
- IOLCP
- Harman Finochem
- Farmhispania
- Exemed Pharmaceuticals
- Bhupinder Singh Manhas
- Auro Laboratories Limited
- Atom Pharma
- Anant Pharmaceuticals Pvt. Ltd.
- Abhilasha Pharma Pvt. Ltd.
- Aarti Drugs
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Metformin HCl API Market Size (2021-2032)
- 2.2.2 Global Metformin HCl API Sales (2021-2032)
- 2.2.3 Global Metformin HCl API Market Average Price (2021-2032)
- 2.3 Metformin HCl API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 0.995
- 2.3.3 0.99
- 2.3.4 0.97
- 2.3.5 Others
- 2.4 Metformin HCl API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical Companies
- 2.4.3 Contract Research Organizations
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metformin HCl API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Metformin HCl API Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Metformin HCl API Revenue of Manufacturers (2021-2026)
- 3.4 Global Metformin HCl API Average Price by Manufacturers (2021-2026)
- 3.5 Global Metformin HCl API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Metformin HCl API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Metformin HCl API, Product Type & Application
- 3.8 Global Manufacturers of Metformin HCl API, Established Date
- 3.9 Global Metformin HCl API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shijiazhuang Polee Pharmaceutical
- 4.1.1 Shijiazhuang Polee Pharmaceutical Company Information
- 4.1.2 Shijiazhuang Polee Pharmaceutical Business Overview
- 4.1.3 Shijiazhuang Polee Pharmaceutical Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shijiazhuang Polee Pharmaceutical Metformin HCl API Product Portfolio
- 4.1.5 Shijiazhuang Polee Pharmaceutical Recent Developments
- 4.2 Shouguang Fukang Pharmaceutical
- 4.2.1 Shouguang Fukang Pharmaceutical Company Information
- 4.2.2 Shouguang Fukang Pharmaceutical Business Overview
- 4.2.3 Shouguang Fukang Pharmaceutical Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shouguang Fukang Pharmaceutical Metformin HCl API Product Portfolio
- 4.2.5 Shouguang Fukang Pharmaceutical Recent Developments
- 4.3 CR Double-Crane
- 4.3.1 CR Double-Crane Company Information
- 4.3.2 CR Double-Crane Business Overview
- 4.3.3 CR Double-Crane Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CR Double-Crane Metformin HCl API Product Portfolio
- 4.3.5 CR Double-Crane Recent Developments
- 4.4 Vistin Pharma
- 4.4.1 Vistin Pharma Company Information
- 4.4.2 Vistin Pharma Business Overview
- 4.4.3 Vistin Pharma Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Vistin Pharma Metformin HCl API Product Portfolio
- 4.4.5 Vistin Pharma Recent Developments
- 4.5 IOLCP
- 4.5.1 IOLCP Company Information
- 4.5.2 IOLCP Business Overview
- 4.5.3 IOLCP Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 IOLCP Metformin HCl API Product Portfolio
- 4.5.5 IOLCP Recent Developments
- 4.6 Harman Finochem
- 4.6.1 Harman Finochem Company Information
- 4.6.2 Harman Finochem Business Overview
- 4.6.3 Harman Finochem Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Harman Finochem Metformin HCl API Product Portfolio
- 4.6.5 Harman Finochem Recent Developments
- 4.7 Farmhispania
- 4.7.1 Farmhispania Company Information
- 4.7.2 Farmhispania Business Overview
- 4.7.3 Farmhispania Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Farmhispania Metformin HCl API Product Portfolio
- 4.7.5 Farmhispania Recent Developments
- 4.8 Exemed Pharmaceuticals
- 4.8.1 Exemed Pharmaceuticals Company Information
- 4.8.2 Exemed Pharmaceuticals Business Overview
- 4.8.3 Exemed Pharmaceuticals Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Exemed Pharmaceuticals Metformin HCl API Product Portfolio
- 4.8.5 Exemed Pharmaceuticals Recent Developments
- 4.9 Bhupinder Singh Manhas
- 4.9.1 Bhupinder Singh Manhas Company Information
- 4.9.2 Bhupinder Singh Manhas Business Overview
- 4.9.3 Bhupinder Singh Manhas Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Bhupinder Singh Manhas Metformin HCl API Product Portfolio
- 4.9.5 Bhupinder Singh Manhas Recent Developments
- 4.10 Auro Laboratories Limited
- 4.10.1 Auro Laboratories Limited Company Information
- 4.10.2 Auro Laboratories Limited Business Overview
- 4.10.3 Auro Laboratories Limited Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Auro Laboratories Limited Metformin HCl API Product Portfolio
- 4.10.5 Auro Laboratories Limited Recent Developments
- 4.11 Atom Pharma
- 4.11.1 Atom Pharma Company Information
- 4.11.2 Atom Pharma Business Overview
- 4.11.3 Atom Pharma Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Atom Pharma Metformin HCl API Product Portfolio
- 4.11.5 Atom Pharma Recent Developments
- 4.12 Anant Pharmaceuticals Pvt. Ltd.
- 4.12.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
- 4.12.2 Anant Pharmaceuticals Pvt. Ltd. Business Overview
- 4.12.3 Anant Pharmaceuticals Pvt. Ltd. Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Anant Pharmaceuticals Pvt. Ltd. Metformin HCl API Product Portfolio
- 4.12.5 Anant Pharmaceuticals Pvt. Ltd. Recent Developments
- 4.13 Abhilasha Pharma Pvt. Ltd.
- 4.13.1 Abhilasha Pharma Pvt. Ltd. Company Information
- 4.13.2 Abhilasha Pharma Pvt. Ltd. Business Overview
- 4.13.3 Abhilasha Pharma Pvt. Ltd. Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Abhilasha Pharma Pvt. Ltd. Metformin HCl API Product Portfolio
- 4.13.5 Abhilasha Pharma Pvt. Ltd. Recent Developments
- 4.14 Aarti Drugs
- 4.14.1 Aarti Drugs Company Information
- 4.14.2 Aarti Drugs Business Overview
- 4.14.3 Aarti Drugs Metformin HCl API Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Aarti Drugs Metformin HCl API Product Portfolio
- 4.14.5 Aarti Drugs Recent Developments
5 Global Metformin HCl API Market Scenario by Region
- 5.1 Global Metformin HCl API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metformin HCl API Sales by Region: 2021-2032
- 5.2.1 Global Metformin HCl API Sales by Region: 2021-2026
- 5.2.2 Global Metformin HCl API Sales by Region: 2027-2032
- 5.3 Global Metformin HCl API Revenue by Region: 2021-2032
- 5.3.1 Global Metformin HCl API Revenue by Region: 2021-2026
- 5.3.2 Global Metformin HCl API Revenue by Region: 2027-2032
- 5.4 North America Metformin HCl API Market Facts & Figures by Country
- 5.4.1 North America Metformin HCl API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Metformin HCl API Sales by Country (2021-2032)
- 5.4.3 North America Metformin HCl API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Metformin HCl API Market Facts & Figures by Country
- 5.5.1 Europe Metformin HCl API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Metformin HCl API Sales by Country (2021-2032)
- 5.5.3 Europe Metformin HCl API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Metformin HCl API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Metformin HCl API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Metformin HCl API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Metformin HCl API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Metformin HCl API Market Facts & Figures by Country
- 5.7.1 South America Metformin HCl API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Metformin HCl API Sales by Country (2021-2032)
- 5.7.3 South America Metformin HCl API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Metformin HCl API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Metformin HCl API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Metformin HCl API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Metformin HCl API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Metformin HCl API Sales by Type (2021-2032)
- 6.1.1 Global Metformin HCl API Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Metformin HCl API Sales Market Share by Type (2021-2032)
- 6.2 Global Metformin HCl API Revenue by Type (2021-2032)
- 6.2.1 Global Metformin HCl API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Metformin HCl API Revenue Market Share by Type (2021-2032)
- 6.3 Global Metformin HCl API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Metformin HCl API Sales by Application (2021-2032)
- 7.1.1 Global Metformin HCl API Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Metformin HCl API Sales Market Share by Application (2021-2032)
- 7.2 Global Metformin HCl API Revenue by Application (2021-2032)
- 7.2.1 Global Metformin HCl API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Metformin HCl API Revenue Market Share by Application (2021-2032)
- 7.3 Global Metformin HCl API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Metformin HCl API Value Chain Analysis
- 8.1.1 Metformin HCl API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Metformin HCl API Production Mode & Process
- 8.2 Metformin HCl API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Metformin HCl API Distributors
- 8.2.3 Metformin HCl API Customers
9 Global Metformin HCl API Analyzing Market Dynamics
- 9.1 Metformin HCl API Industry Trends
- 9.2 Metformin HCl API Industry Drivers
- 9.3 Metformin HCl API Industry Opportunities and Challenges
- 9.4 Metformin HCl API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst